MAL25096006ACSZPrescription (MAL-A)

Glyxambi Film-Coated Tablets 25mg/5mg (Empagliflozin 25mg/ Linagliptin 5mg)

Generic Molecule: Empagliflozin

ACTIVE & APPROVEDValid till: 8 Sept 2030
NPRA Official Regulatory Summary

Glyxambi Film-Coated Tablets 25mg/5mg (Empagliflozin 25mg/ Linagliptin 5mg) is a KKM-approved Prescription Medicine registered under MAL number MAL25096006ACSZ by BOEHRINGER INGELHEIM (MALAYSIA) SDN. BHD.. Its active ingredient is Empagliflozin 25.00 mg, LINAGLIPTIN 5.00 mg, manufactured by ROTTENDORF PHARMA GMBH.

Holder (PRH)
BOEHRINGER INGELHEIM (MALAYSIA) SDN. BHD.
Manufacturer
ROTTENDORF PHARMA GMBH
First Registered
8 Sept 2025
Validity
8 Sept 2030

Prescription Required (Schedule Poison)

Need a valid doctor's prescription renewal in Malaysia?

Consult Online Doctor (Telehealth)

Active Ingredients & Strength Formulation

2 Components
Active Substance / MoleculeDeclared Strength / DosageGeneric Directory
Empagliflozin25.00 mgFind Brands
LINAGLIPTIN5.00 mgFind Brands
Dosage values indicate declared active concentration per unit dose as registered with NPRA Malaysia.

Malaysian KKM Security Hologram Verification

FarmaChecker & Meditag™

By Malaysian Ministry of Health (KKM) regulation, all genuine registered pharmaceuticals, health supplements (MAL-N), and traditional products (MAL-T) distributed in Malaysia must feature an official tamper-evident security hologram sticker on the physical packaging.

1. Visual Tilt Check

Tilt the box under light to view the micro-engraved KKM coat of arms and multi-layer iridescent security patterns.

2. Match MAL Number

Ensure the printed MAL code matches MAL25096006ACSZ exactly on label and box.

3. FarmaChecker Scan

Scan using the official FarmaChecker app on iOS / Android to authenticate serial token with NPRA servers.

If the packaging lacks a security hologram or fails the FarmaChecker scan, do not consume and report to Cawangan Penguatkuasaan Farmasi (CPF KKM).
Frequently Asked Questions & Verification Details

Is Glyxambi Film-Coated Tablets 25mg/5mg (Empagliflozin 25mg/ Linagliptin 5mg) approved by KKM / NPRA?

Yes. Glyxambi Film-Coated Tablets 25mg/5mg (Empagliflozin 25mg/ Linagliptin 5mg) is actively registered with the National Pharmaceutical Regulatory Agency under official registration number MAL25096006ACSZ with current status PRODUCT APPROVED. Registration was filed by BOEHRINGER INGELHEIM (MALAYSIA) SDN. BHD..

What are the active ingredients of Glyxambi Film-Coated Tablets 25mg/5mg (Empagliflozin 25mg/ Linagliptin 5mg)?

The declared active therapeutic components are: Empagliflozin 25.00 mg, LINAGLIPTIN 5.00 mg. Always follow dosage recommendations prescribed by a certified doctor or licensed pharmacist.

What are the registered generic alternatives in Malaysia?

In Malaysia, there are 12 registered brand formulations containing identical active ingredients (Empagliflozin). You can review them in the alternative brands section above or consult your community pharmacist for generic bioequivalent substitution.

Semakan status pendaftaran KKM / NPRA: Glyxambi Film-Coated Tablets 25mg/5mg (Empagliflozin 25mg/ Linagliptin 5mg) (MAL25096006ACSZ) | Pengganti ubat di Malaysia | Bahan aktif ubat & maklumat farmasi.